Results

Total Results: 2,116 records

Showing results for "risks".

241. ASSESSING THE QUALITY OF INCLUDED STUDIES (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
     June 02, 2011 - protocol Yes No No Conflict of interest No No Yes (optional domain of publication bias ) Types of Risks … Each study design has specific risks of bias that may differ depending on the clinical question. … classes of evidence into the review and (2) when evaluating individual studies for design-specific risks … to include observational studies, then the review team needs to evaluate each study based on the risks … presenting data on individual endpoints; 26 2. selective outcome reporting—for example, reporting relative

242. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
     April 01, 2020 - Harms and adverse events: – What are the risks of nonopioid pharmacologic agents for harms including … points on a 0 to 100-point scale • SMD >0.8 • RR/OR ≥2.0 MD = mean difference; OR = odds ratio; RR = relative … response with SNRI antidepressants (odds ratio [OR] 1.61 to 2.33) while we found a moderate effect (relative … ).15 Differences in magnitude could be due to the addition of 15 studies in our report, reporting relative … risks rather than odds ratios, and using direct comparisons rather than network analysis.

243. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
     October 10, 2019 - risks (RRs), and hazard ratios (HRs). … risks. … Deaths due to brain metastases (number of patients, relative risk) 5. … Key results that are based on measure-independent effect estimates, such as relative risks or standardized … of bias RR relative risk SD standard deviation SMD standardized mean difference SRS stereotactic

244. AHRQ Evidence-based Practice Center Program Research Gaps Summary: Primary Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
     March 01, 2022 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … • Studies on the acute treatment of migraine that compare relative risks of medication overuse … studies that looked at prior or early postoperative opioid use found mostly strong associations (e.g., relative … Outcomes • Studies to assess risks and benefits including patient anxiety and disproportionate access … with antiresorptive osteoporosis drug treatment to best place these risks in the context of the effects

245. Omega-3 Fatty Acids and Maternal and Child Health: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
     October 01, 2016 - observational studies found no consistent effects of maternal or infant n-3 FA supplementation on risks … Key Question 3: Maternal or childhood adverse events: – What are the short and long-term risks related … Breastfeeding women o Term or preterm human infants at or after birth – What are the short and long-term risks … Dermatitis, and Respiratory Conditions Additional outcomes newly included in the current report were risks … for atopic dermatitis/eczema, risks for allergies, and risks for respiratory illnesses, including asthma

246. S81 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
     October 01, 2007 - commonly used measure of discrimination, in this case equal to (sensi- tivity � specificity)/2,22 and relative … risk (RR). … risk. … 31 38.21 0.0000 Diabetes Mellitus (CCS D-50)† 0.08 4 11 97 0.54 3 3.41 0.0134 *P value is for the relative … risk.

247. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
     March 01, 2024 - in risk. … There were no significant differences in risks for acute kidney injury, cardiac arrhythmia, infection … Risks for acute kidney injury, hypertension, hypotension, seizure, and transfusion-associated lung injury … Studies from other regions might also report elevated risks for additional serious adverse events. … Assessment RoB: Low risk Reporting RoB: Low risk Overall RoB: Low risk Pub.

248. AHRQ Slide Template-Widescreen
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-child-adolesc-mental-health-grand-rounds.pptx
     May 22, 2025 - of Bias Strength of Evidence (SoE) across studies by considering risk of risk of bias, consistency, … from communities at risk. … The program uses cultural considerations to inform multi-component treatments designed to address risks … CAMS is guided by the Suicide Status Form (SSF), which is used to identify risks and contributors to … The program uses cultural considerations to inform multi-component treatments designed to address risks

249. M (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/systematicreviewsreplacedenovo.pdf
     September 01, 2009 - Effectiveness Reviews Key Points • Using existing systematic reviews (SRs) has potential benefits and risks … Conversely, five main risks are associated with using existing SRs in CERs that do not arise in a purely … The use of existing SRs to substitute for purely de novo CER methods may provide benefits and risks. … to a CER’s comprehensiveness and transparency or the risk of introducing bias. … of interest.6 Commonly Used SR Quality Instruments In assessing the quality (i.e., assessing the risk

250. M (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-de-novo-processes_methods.pdf
     September 01, 2009 - Effectiveness Reviews Key Points • Using existing systematic reviews (SRs) has potential benefits and risks … Conversely, five main risks are associated with using existing SRs in CERs that do not arise in a purely … The use of existing SRs to substitute for purely de novo CER methods may provide benefits and risks. … to a CER’s comprehensiveness and transparency or the risk of introducing bias. … of interest.6 Commonly Used SR Quality Instruments In assessing the quality (i.e., assessing the risk

251. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
     January 01, 2009 - Relative Risks (RRs): The ratio of an event occurring in an exposed group to an event occurring in … results reported as relative risk, likely reflects hazard ratio Moorcroft, 1997 10 N=92 … risk, likely reflects relative risk Sharples, 1993 5 N=67 Adult patients with CF accepted … risk, likely reflects relative risk F-11 Appendix Table F2. … RR 3.25 (95%CI 1.27, 3.25) NR Univariate results reported as relative risk, likely reflects

252. Heart-Failure-Transition-Care Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_executive.pdf
     May 01, 2014 - Effective Health Care Program 2 uncontrolled hypertension are the two highest population- attributable risks … Risk-of-Bias Assessment of Individual Studies To assess the risk of bias (internal validity) of studies … the risk of bias for each study. … For binary outcomes, we calculated relative risks (RRs) and 95% confidence intervals (CIs). … bNA entry for NNT indicates that the relative risk (95% CI) was not statistically significant, so we

253. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
     October 01, 2021 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … of sedation, and large increased risk of nausea. … Synthetic THC is probably associated with a large increased risk of dizziness. … -point scale • SMD >0.8 • RR/OR ≥2.0 Abbreviations: MD = mean difference; OR = odds ratio; RR = relative … risk; SMD = standardized mean difference.

254. Prehospital EMS Blood Transfusion and Fluid Interventions for Hemorrhagic Shock (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol.pdf
     September 24, 2024 - Assessment of Methodological Risk of Bias of Individual Studies We define the risk of bias as the risk … Studies will be rated as “low risk of bias,” “medium risk of bias,” or “high risk of bias.” … Studies rated “low risk of bias” are considered to have the least risk of bias, and their results are … 100-point scale SMD >0.8 RR/OR ≥2.0 Abbreviations: MD = mean difference; OR = odds ratio; RR = relative … quality improvement; RCT = randomized controlled trial; ROSC = return of spontaneous circulation; RR = relative

255. AHRQ Evidence-Based Practice Center (EPC) Program Research Gaps Summary: Pain Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
     January 01, 2023 - There may be a large increased risk of dizziness and sedation and a moderately increased risk of nausea … of sedation, and large increased risk of nausea and dizziness … Extracted whole-plant products with higher THC than CBD may be associated with large increases in risk … • Studies on the acute treatment of migraine that compare relative risks of medication-overuse … use of risk prediction instruments impacts treatment decisions and outcomes.

256. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
     December 01, 2017 - However, reduced risk of severe exacerbations was suggested (low SOE), although the clinical importance … availabl literature, BT may be modestly beneficial in some patients with asthma, but is not without risks … The risk of adverse events is higher early in treatment, while benefit is typically observed weeks to

257. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
     June 01, 2015 -  Key Expert Comments: Programs such as MSHOP may address an unmet need for reducing surgical risks … that clinicians would be likely to adopt a MSHOP-like program based on the potential to decrease risks … Most experts commenting on this intervention agreed that an unmet need exists for reducing surgical risks … Unmet need and health outcomes: An unmet need exists to decrease surgical risks and complications, … biggest hurdle, which is patient compliance.67 Acceptance and adoption: The potential to decrease risks

258. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - number of available tests and testing strategies, and potential tradeoffs in diagnostic accuracy, risks … We calculated relative risks (RRs) and associated 95% confidence intervals (CIs) based on the information … risk of adverse events (SOE: low) … optimized administration to be associated with lower risk of recurrence and increased risk of local … NMIBC = non–muscle-invasive bladder cancer; NMP22 = nuclear matrix protein 22; OR = odds ratio; RR = relative

259. Technical Brief Protocol: Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/community-health-worker-protocol.pdf
     March 26, 2019 - and knowledge base, and increase funding for services.5, 8-11 On the other hand, there are important risks … the overarching goal of this project is to assess the current state of evidence of the processes, risks … ROBIS: A new tool to assess risk of bias in systematic reviews was developed.

260. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - Based on a single RCT with moderate risk of bias, we found low strength of evidence that the risk of … combination therapy containing rosiglitazone than with a combination of metformin and a sulfonylurea (relative … risk [RR] 2.1). … Hypoglycemia High The risk of mild to moderate hypoglycemia with sulfonylureas exceeds the risk with … low density lipoproteins; mg/dL = milligrams per deciliter; RCT = randomized controlled trial; RR = relative